IRCT2012100711026N1已完成未知
Clinical trial of a chosen drug of Persian medicine on dysuria during radiotherapy for localized prostate cancer
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- no limit 至 no limit（—）
- 性别
- Male
入选标准
- •patients who are planed radiotherapy with impression of prostate adenocarcinema and signed informed consent, those who are able to Express dysuria and do not have not have foley catheter.
- •exclusion criteria: Drug or placebo sensitivity and positive urine culture indicative of infection.
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
1 期
Ratifying dosage and duration for levo-bupivacaine, a local anaesthetic infusion by the caudal-epidural route in infants 3-6 months.EUCTR2015-000393-34-GBCentral Manchester University Hospitals NHS Foundation Trust10
尚未招募
3 期
To evaluate the effect of a Persian medicine product, containing silk, on the incidence of pregnancy in infertile women with polycystic ovary syndromIRCT20221009056122N1Ghoum University of Medical Sciences58
已完成
2 期
The explorative clinical trial of a medicine for treatment of CIN (Cervical Intraepithelial Neoplasia) using lactobacillus to HPV16 positive CIN 2.Cervical Intraepithelial Neoplasia 2 (CIN2)JPRN-UMIN000012229The University of Tokyo Hospital Department of Obstetrics & Gynecology40
尚未招募
2 期
A Unani remedy for Acne.CTRI/2022/10/046912Department of Amraze jild wa zohrawiya Ajmal khan Tibbia College
进行中（未招募）
不适用
study of effective pharmacological cardioversion of paroxysmal atrial fibrillation with flecainide vs vernakalantAtrial fibrillation paroxysmalMedDRA version: 17.1Level: LLTClassification code 10003661Term: Atrial fibrillation paroxysmalSystem Organ Class: 100000004849EUCTR2014-003641-95-ESicasio Pérez Castellano